Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2019-07-14 16:36:32 UTC |
---|
Last Updated | 2019-10-01 21:41:19 UTC |
---|
CypComp ID | CC02049 |
---|
Compound Information |
---|
Name | Tegaserod |
---|
Structure Image | |
---|
InChIKey | IKBKZGMPCYNSLU-RGVLZGJSSA-N |
---|
PubChem ID | 135409453 |
---|
CypCompound Information |
---|
Set | CypBoM Training Set |
---|
Bonds of Metabolism (BoMs) | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | - <14,12;Cleavage;R1>
- <14,H;Oxidation;R1>
| | | | | | - <14,12;Cleavage;R1>
- <14,H;Oxidation;R1>
| | |
|
---|
References | - Vickers AE, Zollinger M, Dannecker R, Tynes R, Heitz F, Fischer V: In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions. Drug Metab Dispos. 2001 Oct;29(10):1269-76. [PubMed:11560869 ]
|
---|
Download File | CC02049.sdf |
---|